You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽諾醫療(688108.SH):上半年營收預增46.22%至1.61億元
格隆匯 07-30 18:17

格隆匯7月30日丨賽諾醫療(688108.SH)公佈2023年半年度業績預吿,報吿期內,預計本報吿期營業收入為16,129萬元,較上年同期增加5,098萬元,同比增長46.22%。

報吿期內,預計實現歸屬於上市公司股東的淨利潤與上年同期相比將減少虧損,實現歸屬於上市公司股東的淨利潤為-2,961萬元,較上年同期增加4,162萬元,同比增長58.43%。

報吿期內,預計實現歸屬於上市公司股東的扣除非經常性損益後的淨利潤為-3,498萬元,較上年同期增加3,864萬元,同比增長52.48%。

報吿期內,公司預計營業收入較上年同期增長46.22%,主要原因如下:1、冠脈介入業務營業收入預計同比增長57.19%,主要系本報吿期是國家二輪冠脈支架帶量集中採購政策落地實施的第一年,公司兩款冠脈支架產品進入集採範圍,冠脈支架產品銷量大幅上升,預計冠脈介入業務板塊營業收入約為7,170萬,較上年同期增加2,609萬,同比增長57.19%;2、神經介入業務營業收入預計同比增長36.66%,主要系本報吿期神經介入業務持續增長,顱內球囊和顱內支架產品預計同比分別增長15.74%和106.56%,預計神經業務板塊收入約為8,828萬元,較上年同期增加2,368萬元,同比增長36.66%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account